ClinicalTrials.gov
public full text
Public Domain
"Treatment of Active HBV With γδT Cells" Clinical Trial Protocol
To evaluate the safety and anti-HBV efficacy of γδT cells.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Follow the “DOTs”: Vδ1(+) γδ T cells as effectors of cancer immunotherapy#360966
- CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)#886291
- CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies#878848
- A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application#18597
- CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies#846096
Record · ID 854095
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive